IDEXX Laboratories, Inc. (FRA:IX1)
Germany · Delayed Price · Currency is EUR 561.20
-10.20 (-1.79%)
At close: Jan 30, 2026
IDEXX Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 1,027 | 887.87 | 845.04 | 679.09 | 744.85 | 581.78 |
Depreciation & Amortization | 140.17 | 129.94 | 114.91 | 111.9 | 104.6 | 96 |
Asset Writedown & Restructuring Costs | - | 0.25 | 1.48 | 2.35 | 5.15 | 2.5 |
Stock-Based Compensation | 58.16 | 60.3 | 59.74 | 49.77 | 37.76 | 30.95 |
Provision & Write-off of Bad Debts | 7.77 | 6.87 | 5.55 | 5.83 | 1.48 | 4.95 |
Other Operating Activities | 107.78 | -22.98 | -47.79 | -32.42 | -0.76 | -36.35 |
Change in Accounts Receivable | -54.78 | -28.28 | -53.87 | -41.4 | -33.14 | -60.72 |
Change in Inventory | -5.45 | -28 | -28.65 | -121.73 | -52.92 | -18.89 |
Change in Accounts Payable | 0.76 | 8.09 | -0.56 | 3.47 | 11.23 | 0.98 |
Change in Unearned Revenue | 2.57 | -4.38 | -3.03 | -11.02 | -7.55 | -13.37 |
Change in Other Net Operating Assets | -196.34 | -80.67 | 13.68 | -102.85 | -55.15 | 60.24 |
Operating Cash Flow | 1,088 | 929 | 906.51 | 542.98 | 755.55 | 648.06 |
Operating Cash Flow Growth | 18.68% | 2.48% | 66.95% | -28.13% | 16.59% | 41.14% |
Capital Expenditures | -124.5 | -120.92 | -133.63 | -148.84 | -119.55 | -106.96 |
Cash Acquisitions | - | -76.69 | - | -11.51 | -173.42 | -1.5 |
Sale (Purchase) of Intangibles | -23.35 | -10 | - | -10 | - | -0.67 |
Investment in Securities | -1.76 | -1 | - | -25 | - | -0.25 |
Other Investing Activities | 1.66 | 1.56 | 8.38 | - | - | - |
Investing Cash Flow | -147.95 | -207.06 | -125.25 | -195.35 | -292.97 | -109.38 |
Short-Term Debt Issued | - | - | - | 505.5 | 73.5 | - |
Long-Term Debt Issued | - | - | - | - | - | 200 |
Total Debt Issued | 205 | - | - | 505.5 | 73.5 | 200 |
Short-Term Debt Repaid | - | - | -329 | - | - | - |
Long-Term Debt Repaid | - | -75 | -75 | -75 | -50 | -289.63 |
Total Debt Repaid | -103.39 | -75 | -404 | -75 | -50 | -289.63 |
Net Debt Issued (Repaid) | 101.61 | -75 | -404 | 430.5 | 23.5 | -89.63 |
Issuance of Common Stock | 88.75 | 44.49 | 47.03 | 35.75 | 46.57 | 51.33 |
Repurchase of Common Stock | -1,232 | -847.57 | -81.9 | -830.32 | -762.34 | -203.42 |
Other Financing Activities | - | - | -3.14 | -6.87 | -5.14 | -6.7 |
Financing Cash Flow | -1,042 | -878.07 | -442 | -370.94 | -697.41 | -248.42 |
Foreign Exchange Rate Adjustments | 1.46 | -9.53 | 2.13 | -8.61 | -4.64 | 3.33 |
Net Cash Flow | -100.47 | -165.67 | 341.39 | -31.91 | -239.47 | 293.6 |
Free Cash Flow | 963.57 | 808.08 | 772.88 | 394.15 | 636 | 541.11 |
Free Cash Flow Growth | 21.57% | 4.55% | 96.09% | -38.03% | 17.54% | 77.88% |
Free Cash Flow Margin | 23.12% | 20.73% | 21.11% | 11.71% | 19.78% | 19.99% |
Free Cash Flow Per Share | 11.82 | 9.71 | 9.20 | 4.66 | 7.35 | 6.24 |
Cash Interest Paid | 33.8 | 33.8 | 41 | 40.3 | 30.5 | 32.4 |
Cash Income Tax Paid | 224.2 | 307.2 | 192.5 | 239.8 | 161.7 | 110.7 |
Levered Free Cash Flow | 675.23 | 734.99 | 693.69 | 328.16 | 534.41 | 436.95 |
Unlevered Free Cash Flow | 698.44 | 754.49 | 719.68 | 353.07 | 553.04 | 457.65 |
Change in Working Capital | -253.23 | -133.24 | -72.43 | -273.53 | -137.52 | -31.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.